Since 2016, he is also director of the Center for Antibiotic Resistance Research (CARe) at the University of Gothenburg.[2]
Research
Larsson's discovery that ethinylestradiol contributed to the feminization of fish in 1999[3] was one of the triggering factors for today's widespread concern about pharmaceuticals in the environment.[4]
His discovery of significant antibiotic emissions from pharmaceutical manufacturing in India[5] has gained significant attention,[6] including in several documentary films.[7][8][9]
This and subsequent research studies from Larsson's research group, including threshold values for emissions,[10] have led to various societal measures, including:
Voluntary commitments from many of the world's largest pharmaceutical companies to reduce industrial antibiotic emissions and the development of an international emissions standard.[12]
The introduction of environmental criteria in the procurement of pharmaceuticals in Sweden and Norway.[12]
A revision of the Swedish model for generic substitution of drugs that takes into account companies' emissions control.[13]
Several UN organizations,[14] the European Parliament, and the G7 have expressed an international need for similar measures, including increased transparency in the pharmaceutical production chain.
Joakim Larsson has published over 200 scientific articles.[15] Since 2018, he has been among the top 1% most highly cited researchers in the world according to Web of Science[16]
Awards and honors
Larsson was the recipient of the first Swedish award for effective research communication (2023), established by Örebro University and the Hamrin Foundation.[17] He also received the Eric K. Fernström Prize for young, particularly promising, and successful researchers in 2012.
This article needs additional or more specific categories. Please help out by adding categories to it so that it can be listed with similar articles.(January 2024)